HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael C Pirrung Selected Research

Michael C Pirrung Research Topics

Disease

9Neoplasms (Cancer)
01/2022 - 05/2002
6Multiple Myeloma
01/2022 - 09/2011
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2020 - 01/2012
2Triple Negative Breast Neoplasms
01/2022 - 01/2013
2Neuroblastoma
04/2016 - 01/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Peripheral Nervous System Diseases (PNS Diseases)
01/2020
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Cardiotoxicity
01/2020
1Hypoglycemia (Reactive Hypoglycemia)
01/2013
1Carcinogenesis
01/2013
1Hypoxia (Hypoxemia)
01/2013
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
09/2011
1Lymphoid Leukemia
09/2011
1Dehydration (Water Stress)
06/2009
1Alzheimer Disease (Alzheimer's Disease)
12/2008
1Type 2 Diabetes Mellitus (MODY)
11/2007
1Smallpox (Variola)
04/2005
1Arteriosclerosis
05/2003
1Breast Neoplasms (Breast Cancer)
05/2002

Drug/Important Bio-Agent (IBA)

4Proteasome Endopeptidase Complex (Proteasome)IBA
01/2022 - 09/2011
3TIR-199IBA
01/2022 - 04/2016
3Bortezomib (Velcade)FDA Link
01/2020 - 01/2012
3Proteasome InhibitorsIBA
01/2020 - 01/2012
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2013 - 11/2007
2Glucose (Dextrose)FDA LinkGeneric
01/2013 - 05/2003
1ixazomibIBA
04/2016
1syringolin AIBA
04/2016
1carfilzomibIBA
04/2016
1Deoxyglucose (2 Deoxy D glucose)IBA
01/2013
1TunicamycinIBA
01/2013
1Endoplasmic Reticulum Chaperone BiPIBA
01/2013
1verrucosidinIBA
01/2013
1Proteins (Proteins, Gene)FDA Link
01/2013
1ThapsigarginIBA
01/2013
1syringolin BIBA
01/2012
1TIR-203IBA
01/2012
1Antineoplastic Agents (Antineoplastics)IBA
01/2012
1Apoptosis Regulatory ProteinsIBA
09/2011
1SurvivinIBA
09/2011
1OxazolesIBA
06/2009
1formamideIBA
06/2009
1Nerve Growth Factors (Neurotrophins)IBA
12/2008
1Antiviral Agents (Antivirals)IBA
04/2005
1Dual-Specificity PhosphatasesIBA
06/2003
1DAQIBA
05/2003
1Insulin (Novolin)FDA Link
05/2003
1Protein Isoforms (Isoforms)IBA
05/2002
1RNA (Ribonucleic Acid)IBA
05/2002

Therapy/Procedure

2Therapeutics
09/2011 - 06/2003